OBL Pharm
Delivering excellence in gastroenterology, cardiology, phlebology, and neurology care through trusted prescription and OTC pharmaceuticals.
Delivering excellence in gastroenterology, cardiology, phlebology, and neurology care through trusted prescription and OTC pharmaceuticals.
OBL Pharm is a pharmaceutical company founded in 1994, dedicated to delivering excellence in gastroenterology, cardiology, phlebology, and neurology care through trusted prescription and OTC pharmaceuticals. This Pharmaceutical company provides a wide range of prescription and over-the-counter pharmaceuticals for gastroenterological, cardiologic, phlebologic, and neurologic diseases. In its latest funding round on 28 December 2018, OBL Pharm received investment from VTB Bank and Sistema JSFC. This Private Equity Round investment underscores the confidence that key players in the finance industry have in OBL Pharm's potential for growth and success in the pharmaceutical market.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 2 | VTB Bank, Sistema JSFC | 28 Dec 2018 |
No recent news or press coverage available for OBL Pharm.
We care about your data, and we'd love to use cookies make your experience better.